ArticleBMJ case reports2021

SKAP2-BRAF fusion and response to an MEK inhibitor in a patient with metastatic melanoma resistant to immunotherapy.

Sonya Minmin Chew et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.